Impaired Glucose Tolerance in Vietnamese Infertile PCOS Women

  • End date
    Dec 30, 2021
  • participants needed
  • sponsor
    Mỹ Đức Hospital
Updated on 18 July 2021
diabetes mellitus
tolerance test
impaired glucose tolerance
oral glucose tolerance test
insulin resistance
polycystic ovary syndrome
glucose tolerance test
infertility treatment


Polycystic ovary syndrome (PCOS) is a common endocrine and reproductive disorder in which insulin resistance (IR) is proposed as a key pathophysiological feature of the disease's symptoms and consequences. Impaired glucose tolerance (IGT) which is a significant consequence of IR, is related to a higher risk of diabetes mellitus, future cardiovascular events, and adverse pregnancy outcomes.


All Vietnamese, infertile women, with PCOS according to the Rotterdam criteria present at IVFMD Tan Binh and IVFMD Phu Nhuan will be enrolled to the study. Phenotypes of PCOS are classified into A, B, C and D due to hyperandrogegism (HA), ovulatory dysfunction (OD) and polycystic ovarian morphology (PCOM)

  • A: HA + OD + PCOM
  • B: HA + OD
  • C: HA + PCOM
  • D: OD + PCOM

All patients enrolled in this study will have:

  • Standard anthropometric data will be done by professional and experience physicians according to standard study protocol: Weight, height, waist and hip circumference, waist to hip ratio, BMI calculated, followed by World Health Organization guidelines for Asian women.
  • Blood pressure
  • Fat mass measure by specific caliper which are available at the clinic. Fat mass index (FMI) are classified as: deficit < 5, normal 5-9, excess female >9-13, obese >13
  • Gynecologic ultrasound scan
  • Blood tests:
  • Hormonal profile evaluation: Luteinizing hormone (LH) (Roche Cobas e411, S: 25.816 mIU/mL, CV: 5.8%), Follicle-stimulating hormone (FSH) (Roche Cobas e411, S: 25.045 mIU/mL, CV: 5.8%), Estradiol (Roche Cobas e411, S: 210.390 ng/L, CV: 6.6%), Total testosterone, SHBG, androstenedione, TSH (Beckman Access - S: 2,712 ng/dL, CV: 5.6%), Total triiodothyronine (total T3) (Beckman Access - S: 7.284 pg/mL, CV: 6.1%), Free thyroxine (free T4) (Beckman Access - S: 2.712 ng/dL, CV: 5.6%), Prolactin (Roche Cobas e411 - S: 37.993 mcg/L, CV: 5.5%), Progesterone (Roche Cobas e411, S:10.553 ng/mL and CV: 5.4%),17(OH)-progesterone (Elisa, DRG International, S: 0.03 ng/ml and CV: 5.8-9.2%), Free androgen index (FAI) = Serum testosterone (nmol/L)/serum SHBG (nmol/L) 100, HDL, LDL, Fasting serum insulin (Roche Cobas e411 - S: 1.39 pmol/L, CV: 1.4%), Insulin sensitivity is estimated by homeostasis model assessment of insulin resistance (1/HOMA-IR) index. HOMA-IR is calculated by the following formula: HOMA-IR = fasting plasma glucose (mmol/L) fasting insulin (uIU/mL)/22.5
  • Glucose tests:
  • Fasting plasma glucose: will be measured by Humastar 600 System (Humastar Systems,), sensitivity (S): 6.421 mmol/L and coefficient of variation (CV): 2.5% and performed when patients have already had fasting for at least 8 hours. A volume of 2 ml of blood will be withdrawn and contained in a vacutainer with additive of natri oxalate and EDTA. Diagnosis of diabetes mellitus will be made when fasting glucose 126 mg/dL (7 nmol/L) or HbA1C 6.5% (48 mmol/mol) (American Diabetes Association, 2018). When glucose 126 mg/dL (7 nmol/L) or HbA1C 6.5% (48 mmol/mol) (American Diabetes Association, 2018).
  • Oral glucose tolerance test with 75 g glucose (75 g OGTT) will be performed to those with normal fasting glucose and HbA1C levels. Women will be recommended to have normal diet for 3 days and overnight fasting for at least 8 hours. The blood withdrawal will be performed twice: (i) fasting and (2i) 2 hours after solution administration. The volume of blood for each test is 2 ml. Impaired glucose tolerance will be diagnosed when two-hour glucose levels of 140 to 199 mg/dL (7.8 to 11.0 mmol/l) (American Diabetes Association, 2018).
  • Hyperandrogenism:
  • Clinical hyperandrogenism: Hirsutism using the modified Ferriman Gallwey score (mFG) and severe acnes
  • Biochemical hyperandrogenism: free testosterone (normal range below 2,53nmol/ml), free testosterone index, SHBG

Condition Prediabetes, Glucose Intolerance, Female Genital Diseases, Infertility, Polycystic Ovary Syndrome, Gynecological Infections, Polycystic Ovarian Syndrome, impaired glucose tolerance, pcos, polycystic ovary disease, sterility, unable to conceive
Treatment Oral glucose tolerance test
Clinical Study IdentifierNCT04364087
SponsorMỹ Đức Hospital
Last Modified on18 July 2021


Yes No Not Sure

Inclusion Criteria

Vietnamese women with polycystic ovarian syndrome diagnosed followed by Rotterdam criteria (2003) having indications for infertility treatments

Exclusion Criteria

Endocrinal abnormalities including thyroid-stimulating hormone (TSH) >5mIU/mL, serum prolactin (PRL) >30ng/mL and any other concomitant endocrinopathy such as a history of hypothyroidism, Cushing's syndrome, premature ovarian insufficiency and late-onset or non-classic congenital adrenal hyperplasia will be excluded
Women who were already diagnosed as diabetes by endocrinologists
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note